A Phase I Study of hEGFRvIII-CD3 bi-scFv (BRiTE) in Patients with WHO Grade IV Malignant Glioma

Clinical Trial Grant

Duke Scholars

Principal Investigator Mustafa Khasraw Neurosurgery

Awarded By

Adaptin Bio, Inc.

Start Date

July 9, 2026

End Date

July 14, 2031

Awarded By

Adaptin Bio, Inc.

Start Date

July 9, 2026

End Date

July 14, 2031